Neoadjuvant chemotherapy provides a means both of improving subsequent surgical
intervention and of testing novel therapies or combinations. Historically, triple-negative …

Purpose To evaluate whether features from texture analysis of breast cancers were
associated with pathologic complete response (pCR) after neoadjuvant chemotherapy and …

Background Prognostic factors in locally advanced breast cancer treated with neoadjuvant
chemotherapy differ from those of early breast cancer. The purpose of this study was to …

MRI and in vivo MRS have rapidly evolved as sensitive tools for diagnosis and therapeutic
monitoring in cancer research. In vivo MRS provides information on tumor metabolism …

Anti-tumor immunity is thought to play a significant role in chemotherapeutic response of
breast tumors. In the present study, we investigated whether tumor infiltrating FOXP3+ …

The potential of total choline (tCho) signal‐to‐noise ratio (SNR)(ChoSNR) and tumor volume
in the assessment of tumor response in locally advanced breast cancer (LABC) patients (n …

Objective: Pathologic complete response (pCR) is the most predictive factor for patients with
neoadjuvant chemotherapy and we investigated the rate of pCR according to molecular …

Purpose To prospectively investigate the influence of taxane-containing neoadjuvant
chemotherapy (T-NACT) versus non–taxane-containing NACT (NT-NACT) on the contrast …

Abnormal choline phospholipid metabolism is a hallmark of cancer. The magnetic
resonance spectroscopy (MRS) detected total choline (tCho) signal can serve as an early …

Aim and objectives To assess the effectiveness of neo-adjuvant chemotherapy and its
impact on the clinical and pathological response in locally advanced breast cancer. To …